Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy

Overview of attention for article published in Frontiers in Cardiovascular Medicine, June 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,794 followers.

New Research: Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy https://t.co/S9CCTDpWIV #cardiovascular

25 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.